Financial statements Apotex
Balance sheet of Apotex
Company age:
Age:
23 y. 10 m. 6 d.
Share capital:
Share capital:
25 000 PLN
Balance sheet data of APOTEX
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 4 932 296,05 | 5 060 469,96 | 5 171 159,84 | 5 198 802,56 | 5 317 029,09 | 5 755 985,17 |
| A. Fixed assets | 405 602,83 | 325 847,55 | 246 420,57 | 170 273,33 | 126 864,38 | 86 794,58 |
| B. Current assets | 4 526 693,22 | 4 734 622,41 | 4 924 739,27 | 5 028 529,23 | 5 190 164,71 | 5 669 190,59 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 4 932 296,05 | 5 060 469,96 | 5 171 159,84 | 5 198 802,56 | 5 317 029,09 | 5 755 966,34 |
| A. Equity | 4 044 392,16 | 4 111 291,29 | 4 216 589,86 | 4 416 543,62 | 4 478 353,17 | 4 759 041,46 |
| B. Liabilities and provisions for liabilities | 887 903,89 | 949 178,67 | 954 569,98 | 782 258,94 | 838 675,92 | 996 924,88 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 887 903,89 | 810 681,65 | 891 956,04 | 723 295,03 | 778 784,88 | 914 596,63 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.